Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.7M Buy
138,765
+6,691
+5% +$772K 0.49% 35
2025
Q4
$13.9M Sell
132,074
-41,293
-24% -$3.88M 0.35% 33
2025
Q3
$14.6M Buy
173,367
+7,658
+5% +$631K 0.34% 35
2025
Q2
$13.1M Buy
165,709
+9,827
+6% +$781K 0.3% 35
2025
Q1
$14M Sell
155,882
-88
-0.1% -$8.22K 0.37% 26
2024
Q4
$15.5M Sell
155,970
-28,509
-15% -$2.94M 0.43% 26
2024
Q3
$20.9M Buy
184,479
+173
+0.1% +$20.6K 0.56% 23
2024
Q2
$22.8M Buy
184,306
+4,963
+3% +$639K 0.64% 21
2024
Q1
$23.7M Buy
179,343
+1,054
+0.6% +$130K 0.72% 20
2023
Q4
$19.4M Buy
178,289
+1,119
+0.6% +$116K 0.68% 21
2023
Q3
$18.2M Buy
177,170
+1,027
+0.6% +$111K 0.67% 22
2023
Q2
$20.3M Buy
176,143
+1,247
+0.7% +$142K 0.69% 23
2023
Q1
$18.6M Buy
174,896
+5,990
+4% +$647K 0.67% 23
2022
Q4
$18.7M Sell
168,906
-2,530
-1% -$259K 0.72% 21
2022
Q3
$14.8M Buy
171,436
+857
+0.5% +$76.5K 0.62% 25
2022
Q2
$15.6M Buy
170,579
+1,253
+0.7% +$111K 0.63% 26
2022
Q1
$13.9M Buy
169,326
+7,402
+5% +$584K 0.44% 36
2021
Q4
$12.4M Buy
161,924
+365
+0.2% +$29.1K 0.4% 42
2021
Q3
$12.1M Buy
161,559
+6,746
+4% +$513K 0.4% 43
2021
Q2
$12M Buy
154,813
+3,454
+2% +$257K 0.38% 40
2021
Q1
$11.1M Buy
151,359
+640
+0.4% +$47.2K 0.39% 40
2020
Q4
$11.8M Sell
150,719
-3,722
-2% -$285K 0.44% 37
2020
Q3
$12.2M Buy
154,441
+18
+0% +$1.41K 0.44% 37
2020
Q2
$11.4M Sell
154,423
-11,676
-7% -$879K 0.45% 37
2020
Q1
$12.2M Buy
166,099
+9,219
+6% +$725K 0.54% 35
2019
Q4
$13.6M Buy
156,880
+920
+0.6% +$75.6K 0.44% 36
2019
Q3
$12.5M Buy
155,960
+9,843
+7% +$789K 0.44% 36
2019
Q2
$11.7M Buy
146,117
+12,407
+9% +$950K 0.4% 34
2019
Q1
$10.6M Buy
133,710
+14,803
+12% +$1.11M 0.4% 34
2018
Q4
$8.67M Buy
118,907
+6,218
+6% +$439K 0.38% 32
2018
Q3
$7.63M Buy
112,689
+7,020
+7% +$447K 0.31% 37
2018
Q2
$6.12M Buy
105,669
+2,500
+2% +$141K 0.28% 43
2018
Q1
$5.36M Buy
103,169
+7,119
+7% +$384K 0.27% 50
2017
Q4
$5.16M Buy
96,050
+1,774
+2% +$98.3K 0.25% 52
2017
Q3
$5.76M Buy
94,276
+2,824
+3% +$171K 0.3% 43
2017
Q2
$5.59M Buy
91,452
+1,076
+1% +$65.5K 0.3% 49
2017
Q1
$5.48M Buy
90,376
+5,355
+6% +$325K 0.31% 49
2016
Q4
$4.78M Buy
85,021
+1,305
+2% +$76.4K 0.31% 49
2016
Q3
$4.99M Buy
83,716
+1,601
+2% +$93.6K 0.32% 45
2016
Q2
$4.51M Buy
82,115
+648
+0.8% +$34.5K 0.31% 41
2016
Q1
$4.11M Buy
81,467
+678
+0.8% +$33.2K 0.33% 44
2015
Q4
$4.07M Buy
80,789
+680
+0.8% +$34.3K 0.34% 40
2015
Q3
$3.77M Buy
80,109
+605
+0.8% +$32.1K 0.31% 51
2015
Q2
$4.32M Buy
79,504
+74
+0.1% +$4.15K 0.33% 47
2015
Q1
$4.36M Buy
79,430
+4,358
+6% +$247K 0.32% 48
2014
Q4
$4.07M Buy
75,072
+1,154
+2% +$64.3K 0.36% 47
2014
Q3
$4.18M Buy
73,918
+5,624
+8% +$316K 0.39% 45
2014
Q2
$3.77M Buy
68,294
+197
+0.3% +$10.7K 0.36% 46
2014
Q1
$3.69M Buy
68,097
+220
+0.3% +$11.4K 0.37% 42
2013
Q4
$3.24M Buy
67,877
+4,152
+7% +$190K 0.36% 48
2013
Q3
$2.9M Sell
63,725
-274
-0.4% -$12.5K 0.34% 50
2013
Q2
$2.84M Buy
+63,999
New +$2.86M 0.55% 46

Other funds holding MRK

Bollard Group's MRK Position: Q1 2026 in Review

Bollard Group increased its Merck (MRK) stake by 5.1% in Q1 2026, buying an estimated $772K and bringing the position to 138,765 shares worth $16.7M. The position accounts for 0.49% of the portfolio, ranked #35.

Bollard Group first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $23.7M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Bollard Group held 138,765 shares of Merck worth $16.7M as of Q1 2026.
  • Bollard Group bought 6,691 Merck shares in Q1 2026, an estimated $772K.
  • Merck made up 0.49% of Bollard Group's portfolio in Q1 2026, its #35 holding.
  • Bollard Group first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Bollard Group's Merck position peaked at $23.7M in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Bollard Group's 13F filing for Q1 2026, filed 14 May 2026.